We are live on
!
Find out more
DY
Dowling & Yahnke Portfolio holdings
AUM
$2.15B
Turnover
6.98%
1-Year Est. Return
10.82%
This Fund
S&P 500
This Quarter
Est. Return
-0.2%
1 Year Est. Return
-10.82%
3 Year Est. Return
+34.82%
5 Year Est. Return
+71.23%
10 Year Est. Return
–
AUM
$795M
AUM Growth
-$5M
(-0.63%)
Cap. Flow
-$111K
Cap. Flow
% of AUM
-0.01%
Top 10 Holdings %
Top 10 Hldgs %
25.95%
Holding
272
New
16
Increased
102
Reduced
113
Closed
8
Avg Time Held
1.8
years
Top 10 Avg Time Held
1.6
years
Top 20 Avg Time Held
1.6
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Evolent Health
EVH
|
+$559K |
| 2 |
AGN
Allergan Inc
AGN
|
+$512K |
| 3 |
DexCom
DXCM
|
+$454K |
| 4 |
Coca-Cola
KO
|
+$405K |
| 5 |
Vanguard FTSE Europe ETF
VGK
|
+$370K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Interactive Brokers
IBKR
|
+$1.11M |
| 2 |
Reliance Steel & Aluminium
RS
|
+$1.04M |
| 3 |
ExxonMobil
XOM
|
+$866K |
| 4 |
Apple
AAPL
|
+$756K |
| 5 |
The Marzetti Company
MZTI
|
+$655K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 20.84% |
| 2 | Healthcare | 16.35% |
| 3 | Consumer Staples | 12.39% |
| 4 | Technology | 11.78% |
| 5 | Financials | 11.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
201
Clorox
CLX
$10.4B
| $449K | 0.06% |
4,316
| – | – |
2013 Q2
8 quarters
|
|
202
Vanguard Morningstar Value ETF
VTV
$190B
| $438K | 0.06% |
5,249
| – | – |
2013 Q2
8 quarters
|
|
203
Vanguard Consumer Staples ETF
VDC
$7.93B
| $434K | 0.05% |
3,475
-130
| -4% | -$16.5K |
2013 Q2
8 quarters
|
|
204
iShares Russell 1000 ETF
IWB
$49.2B
| $425K | 0.05% |
3,662
-135
| -4% | -$15.9K |
2014 Q4
2 quarters
|
|
205
WisdomTree International SmallCap Dividend Fund
DLS
$1.03B
| $414K | 0.05% |
6,860
-685
| -9% | -$42.7K |
2013 Q2
8 quarters
|
|
206
Charles Schwab
SCHW
$163B
| $407K | 0.05% |
12,460
+2,230
| +22% | +$70.5K |
2013 Q2
8 quarters
|
|
207
iShares S&P Small-Cap 600 Value ETF
IJS
$7.55B
| $388K | 0.05% |
6,588
| – | – |
2013 Q2
8 quarters
|
|
|
TYC
208
DELISTED
TYCO INTL PLC COM SHS (IRL)
TYC
| $387K | 0.05% |
9,613
-602
| -6% | -$25.7K |
2013 Q2
8 quarters
|
|
|
WFM
209
DELISTED
Whole Foods Market Inc
WFM
| $384K | 0.05% |
9,728
-1,499
| -13% | -$67K |
2013 Q2
8 quarters
|
|
210
Booking.com
BKNG
$125B
| $379K | 0.05% |
8,225
+1,725
| +27% | +$82.3K |
2013 Q4
6 quarters
|
|
211
iShares MSCI ACWI ex US ETF
ACWX
$17.5B
| $376K | 0.05% |
8,500
| – | – |
2014 Q4
2 quarters
|
|
212
Fiserv Inc
FISV
$25.1B
| $374K | 0.05% |
9,022
+2,680
| +42% | +$108K |
2013 Q2
8 quarters
|
|
213
Lincoln National
LNC
$7.66B
| $371K | 0.05% |
6,273
+23
| +0.4% | +$1.35K |
2013 Q2
8 quarters
|
|
214
Invesco QQQ Trust
QQQ
$487B
| $366K | 0.05% |
3,419
+650
| +23% | +$70.7K |
2014 Q4
2 quarters
|
|
215
Omnicom Group
OMC
$22.1B
| $365K | 0.05% |
5,255
-250
| -5% | -$18.9K |
2013 Q2
8 quarters
|
|
216
Suncor Energy
SU
$88.5B
| $365K | 0.05% |
13,263
-280
| -2% | -$8.46K |
2013 Q2
8 quarters
|
|
217
iShares US Technology ETF
IYW
$25.8B
| $362K | 0.05% |
13,840
| – | – |
2013 Q2
8 quarters
|
|
218
State Street Health Care Select Sector SPDR ETF
XLV
$45.9B
| $361K | 0.05% |
4,854
+105
| +2% | +$7.78K |
2013 Q2
8 quarters
|
|
219
State Street Industrial Select Sector SPDR ETF
XLI
$30.6B
| $356K | 0.04% |
6,590
+638
| +11% | +$35.8K |
2013 Q2
8 quarters
|
|
|
220
Vanguard FTSE Europe ETF
VGK
$29.7B
| $353K | 0.04% |
+6,548
| New | +$370K |
2015 Q2
0 quarters
|
|
|
BHI
221
DELISTED
Baker Hughes
BHI
| $349K | 0.04% |
5,650
-450
| -7% | -$29.4K |
2013 Q2
8 quarters
|
|
222
Vanguard S&P 500 ETF
VOO
$1.05T
| $333K | 0.04% |
1,765
| – | – |
2014 Q1
5 quarters
|
|
223
Vanguard Total World Stock ETF
VT
$82.1B
| $328K | 0.04% |
5,335
-660
| -11% | -$41.8K |
2013 Q2
8 quarters
|
|
224
Altria Group
MO
$123B
| $326K | 0.04% |
6,659
-50
| -0.7% | -$2.53K |
2013 Q2
8 quarters
|
|
225
Invesco FTSE RAFI US 1000 ETF
PRF
$10.1B
| $311K | 0.04% |
+17,175
| New | +$319K |
2015 Q2
0 quarters
|
|
Similar funds
AC
APA
IC
SCA
ACM
W
Dowling & Yahnke's Q2 2015 Portfolio in Review
As of Q2 2015, Dowling & Yahnke held 272 positions worth $795M, down 0.63% from $800M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Dowling & Yahnke's Q2 2015 filing shows 16 new, 102 increased, 113 reduced and 8 closed positions. Its largest new stake was Evolent Health: 30,000 shares worth $585K. The largest sale was Interactive Brokers, an estimated $1.11M.
By sector, the portfolio is most concentrated in Miscellaneous at 21% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Staples.
- Dowling & Yahnke's largest Q2 2015 buy was Evolent Health: 30,000 shares worth $585K.
- Dowling & Yahnke added most to DexCom in Q2 2015, an estimated $454K increase.
- Dowling & Yahnke's biggest Q2 2015 reduction was Reliance Steel & Aluminium, cutting an estimated $1.04M.
- Dowling & Yahnke fully exited Interactive Brokers in Q2 2015, selling an estimated $1.11M.
- Dowling & Yahnke's ten largest holdings make up 26% of its $795M portfolio in Q2 2015.
- Dowling & Yahnke opened 16 new positions and closed 8 in Q2 2015.
- Dowling & Yahnke's portfolio value fell 0.63% quarter-over-quarter to $795M.
Based on Dowling & Yahnke's 13F filing for Q2 2015, filed 22 Jul 2015.